Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapy

Published:2018-05 Issue:2 Volume:66 Page:50-52
ISSN:2452-3186
Container-title:Current Research in Translational Medicine
language:en
Short-container-title:Current Research in Translational Medicine

Author:

Gauthier Jordan,Turtle Cameron J.

Funder

Life Science Discovery Fund

Bezos Family Foundation

Juno Therapeutics, Inc; University of British Columbia Clinical Investigator Program

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference17 articles.

1. CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients;Turtle;J Clin Investig,2016

2. Intent to treat leukemia remission by CD19CAR T cells of defined formulation and dose in children and young adults;Gardner;Blood,2017

3. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N Engl J Med,2014

4. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N Engl J Med,2018

5. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial;Lee;Lancet (Lond, Engl),2015

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An integrated perspective on measuring cytokines to inform CAR-T bioprocessing;Biotechnology Advances;2024-10

2. Advancements in CAR-T Therapy: A Comprehensive Review;Current Cancer Therapy Reviews;2024-05-22

3. Revolutionizing personalized cancer treatment: the synergy of next-generation sequencing and CRISPR/Cas9;Personalized Medicine;2024-05-03

4. Perils and Problems in Bispecific T-Cell Engager Antibodies;Current Drug Safety;2024-02-27

5. Novel immunotherapies for breast cancer: Focus on 2023 findings;International Immunopharmacology;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3